MAPK1 and melanoma: Indeed, there is little information linking miRNAs to the MAPK/ERK signaling pathway, and there is no published evidence for miRNAs directly targeting BRAF, MEK, or ERK, the main components of the MAPK/ERK pathway in melanoma [6, 24].